Skip to main content
Board of Directors
Innovation engine overview
Extracting microbial biodiversity
Screening for new activity
Active compound characterization
Technology platform overview
DEINOVE is pioneering the exploration of “microbial dark matter”
By revealing the metabolic potential of rare bacteria or still classified as uncultivable, the company tackles a global health and economic challenge:
Adoption of the resolutions at the Shareholders’ Extraordinary General Meeting on September 13, 2021
DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company, pioneer in the exploration and...
Implementation of an agreement of notes convertible into new shares for a maximum nominal amount of €10M. Issuance of a first €500,000 tranche
This new agreement with European Select Growth Opportunities Fund enables the issuance of notes...
More press releases